uncontrolled diabetes mellitus type 2 - Nursing Case Study
Pathophysiology
• Primary mechanism: Insulin resistance in peripheral tissues leads to impaired glucose uptake, causing hyperglycemia. Over time, pancreatic β-cells fail due to increased insulin demand and glucotoxicity.
• Secondary mechanism: Chronic hyperglycemia triggers oxidative stress and advanced glycation end products (AGEs) formation. These contribute to endothelial dysfunction, promoting microvascular and macrovascular complications.
• Key complication: Persistent hyperglycemia and resultant endothelial damage can lead to severe complications like diabetic nephropathy, retinopathy, and cardiovascular disease, significantly increasing morbidity and mortality risks.
Patient Profile
Demographics:
62-year-old male, retired construction worker
History:
• Key past medical history: Diagnosed with type 2 diabetes mellitus 15 years ago, hypertension, hyperlipidemia, and chronic kidney disease stage 3
• Current medications: Metformin, insulin glargine, lisinopril, atorvastatin, aspirin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Persistent fatigue and shortness of breath
• Key symptoms: Blurred vision, tingling in hands and feet, increased thirst, frequent urination, recent unintentional weight loss
• Vital signs: Blood pressure 180/110 mmHg, heart rate 105 bpm, respiratory rate 24 breaths per minute, temperature 98.6°F, blood glucose 450 mg/dL, oxygen saturation 91% on room air
Section 1
Initial Assessment Findings:
Upon admission, the initial assessment of the 62-year-old male reveals several critical findings that highlight the severity of his condition and the need for immediate intervention. The patient's physical examination shows significant peripheral edema in the lower extremities, suggesting possible worsening of his chronic kidney disease. Auscultation of the lungs indicates bilateral crackles, particularly at the lung bases, which raises concerns for pulmonary congestion secondary to possible heart failure exacerbation. The patient also exhibits signs of diabetic neuropathy, with decreased sensation to light touch and vibratory sense in both feet, placing him at higher risk for foot ulcers and subsequent infections.
Laboratory results show a significantly elevated HbA1c of 11.5%, confirming the chronic nature of his hyperglycemia. Serum creatinine is markedly elevated at 2.5 mg/dL, reflecting a decline in renal function and progression towards stage 4 chronic kidney disease. Urinalysis reveals microalbuminuria, a key indicator of diabetic nephropathy. Lipid panel results further complicate the picture, with LDL cholesterol at 160 mg/dL and triglycerides at 250 mg/dL, despite current statin therapy, suggesting the need for more aggressive lipid management.
These findings necessitate a multidisciplinary approach to address the patient's complex medical needs. The immediate priorities include optimizing glycemic control, managing hypertension more aggressively to prevent further renal damage, and addressing possible heart failure. The healthcare team must carefully consider medication adjustments, potential contraindications due to renal impairment, and the need for patient education on lifestyle modifications. These efforts aim to stabilize the patient's condition and prevent further complications, setting the stage for the next steps in his care plan.
Section 2
Change in Patient Status:
Within 48 hours of admission, the patient's condition evolves, necessitating further intervention. Despite initial management efforts, the patient develops increasing shortness of breath and orthopnea, indicative of worsening heart failure. A repeat chest X-ray confirms the presence of pulmonary edema, showing diffuse bilateral infiltrates. The patient's blood pressure rises to 180/100 mmHg, and his heart rate increases to 110 beats per minute. His oxygen saturation drops to 88% on room air, requiring supplemental oxygen to maintain adequate levels.
Concurrent laboratory evaluations reveal a troubling trend: his serum creatinine has risen to 3.0 mg/dL, indicating further deterioration of renal function. His B-type natriuretic peptide (BNP) level is elevated at 1500 pg/mL, reinforcing the diagnosis of acute decompensated heart failure. Electrolyte disturbances, including hyponatremia with a sodium level of 128 mmol/L and hyperkalemia with a potassium level of 5.8 mmol/L, add complexity to his management, requiring careful balancing of diuretics and electrolyte replacement.
These developments challenge the healthcare team to reassess the treatment plan, considering the patient's declining renal function and potential contraindications of standard heart failure therapies. The interdisciplinary team must prioritize aggressive diuresis while minimizing renal compromise, possibly involving nephrology for further renal protective strategies. This situation demands advanced clinical judgment to navigate the delicate interplay between heart failure management and renal preservation, setting the stage for the next critical decisions in the patient's care trajectory.
Section 3
As the healthcare team intensifies their efforts to stabilize the patient, they implement an aggressive diuresis protocol using intravenous furosemide, carefully titrated to balance diuretic efficacy with renal function preservation. However, within 12 hours of initiating this regimen, the patient's condition deteriorates further. He becomes increasingly lethargic and confused, with a new onset of slurred speech, raising concerns about potential cerebral complications. Neurological assessment reveals decreased responsiveness and unilateral weakness, prompting an urgent neurologic evaluation.
Concurrently, repeat laboratory tests reveal a worsening electrolyte imbalance: the potassium level has escalated to 6.2 mmol/L, and the sodium level has dropped further to 126 mmol/L. The hyperkalemia poses an immediate threat, necessitating rapid intervention with intravenous calcium gluconate and insulin with glucose to stabilize cardiac membrane potentials and lower serum potassium levels. Additionally, the need for cautious correction of hyponatremia arises, given the risk of osmotic demyelination syndrome with overly rapid correction.
As the patient's respiratory status remains tenuous, with oxygen saturation persistently below 90% despite high-flow oxygen therapy, the team considers advanced respiratory support, including non-invasive ventilation, to alleviate the burden on his compromised cardiac output. This complex interplay of heart failure, renal insufficiency, and possible cerebrovascular event requires the interdisciplinary team to reevaluate the patient's management strategy, emphasizing collaborative decision-making and prioritization of interventions based on the most life-threatening issues. The evolving clinical picture demands vigilant monitoring and swift, informed adjustments to the treatment plan, highlighting the need for advanced critical thinking and dynamic clinical judgment in navigating this challenging scenario.
Section 4
As the healthcare team focuses on the patient's evolving condition, they turn their attention to the urgent neurologic evaluation findings. A CT scan of the brain reveals an acute ischemic stroke in the left middle cerebral artery territory, correlating with the patient's unilateral weakness and speech difficulties. This development demands immediate intervention to prevent further neurological damage. Given the patient's unstable hemodynamic status, the decision is made to proceed with cautious thrombolytic therapy, weighing the risks of bleeding against the potential for improved outcomes. The team meticulously monitors for signs of hemorrhagic transformation, understanding the delicate balance required in managing this critical complication amidst the patient's multiorgan challenges.
Simultaneously, the patient's respiratory status necessitates escalation to non-invasive positive pressure ventilation (NIPPV) as his oxygen saturation continues to hover around 88-89% despite high-flow oxygen support. The intervention aims to improve gas exchange and reduce the workload on his heart, which remains compromised by the interplay of fluid overload and electrolyte disturbances. The patient's blood pressure remains labile, with systolic readings fluctuating between 90 and 105 mmHg, demanding careful titration of vasopressors to maintain cerebral perfusion without exacerbating cardiac strain.
In the midst of these interventions, the patient's response to the hyperkalemia treatment is closely monitored. Within hours, potassium levels decrease to 5.5 mmol/L, providing some relief to the immediate cardiac risk. However, the team remains vigilant for any signs of arrhythmias or further electrolyte shifts. The complexity of the patient's condition underscores the necessity for coordinated, multidisciplinary discussions, where each decision is critically evaluated for its impact on the intricate web of the patient's health issues. As the situation remains fluid, the team prepares for potential complications, including acute kidney injury or further cardiovascular compromise, always ready to adapt their strategy in real-time as new clinical data emerge.
Section 5
As the healthcare team continues to navigate the complexities of the patient's condition, a sudden change in the patient's status demands immediate attention. The patient becomes increasingly lethargic, with a GCS score dropping to 10, necessitating further neurological assessment. The team rapidly conducts a bedside examination, noting increased right-sided weakness and a decline in speech capabilities, now characterized by garbled speech and difficulty following commands. These alarming changes prompt a repeat CT scan of the brain to assess for possible hemorrhagic transformation or expansion of the ischemic stroke.
The repeat CT scan reveals a small area of hemorrhagic conversion at the periphery of the initial ischemic stroke site. This complicates the patient's management, as the risk of further bleeding must be balanced against the need for continued anticoagulation to prevent additional thrombotic events. The patient's INR is measured at 1.8, reflecting a cautious approach to anticoagulation, but necessitating careful monitoring and possible adjustment. In light of these findings, the team convenes to discuss the delicate balance of optimizing cerebral perfusion while minimizing the risk of further hemorrhage, evaluating whether to adjust the thrombolytic protocol or introduce neuroprotective strategies.
Concurrently, the patient's respiratory status shows marginal improvement with NIPPV, as oxygen saturation stabilizes at 92%, offering a glimmer of hope amidst the neurological setbacks. Nevertheless, the team remains acutely aware of the potential for acute respiratory failure, given the patient's labile hemodynamics and persistent electrolyte imbalances. A repeat arterial blood gas analysis reveals a pH of 7.32, PaCO2 of 50 mmHg, and HCO3 of 22 mEq/L, indicating a state of compensated respiratory acidosis. This finding prompts the team to consider further respiratory support options, including potential intubation, while continuously reassessing the patient's fluid status and cardiac output to prevent further compromise. As these dynamic elements unfold, the team remains vigilant, ready to adapt their approach as the patient's journey continues to evolve.